Navigation Links
Kidz-Med Inc. Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season

WESTON, Fla., Sept. 8 /PRNewswire/ -- Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (Pink Sheets: ASFX) and leading U.S. child health and safety product supplier, has announced that they have received a large Purchase Order for Thermofocus units, leading to a significant increase in Thermofocus sales at the start of the cough and cold season for the first week of September 2009 versus the same period in 2008.

According to the Company's unaudited books, during the first week of September 2008, ASR brought in approximately $270.00 in Thermofocus sales, and this year, during the same week, Thermofocus sales are expected to be approximately $30,800.00, of which the majority is attributed to a large sale from Martin Tsai, the President of the Taiwan Center, Inc. of Flushing, NY. The Taiwan Center is a non profit dedicated to helping the well-being of the public worldwide, particularly Taiwanese, by providing services that will ultimately sustain and enhance their lives. The sales revenues noted were derived online and from Babies "R" Us, with online sales holding the majority of the percentage.

American Scientific's CEO, Dr. Christopher F. Tirotta comments: "The start of the cough and cold season this year is much different from that of last year. Many government agencies worldwide are alerting the public to have emergency plans ready and to include getting safety and emergency preparation kits."

"We are excited to have succeeded in receiving a large PO from the Taiwan Center, and hope that our product continues to be seen as an essential item to include in any pandemic preparatory plan," he continues.

In June, ASR reported a historical achievement of receiving $30,000 in online revenue within a month and a half, attributing the success to PR, social media and SEO/SEM tactics which enabled people to find them as a go-to resource. The Company attributes the week's success to the same efforts.

The Kidz-Med Thermofocus, which was used by medical personnel in Asia during the SARS epidemic (See BBC article:, is an ideal instrument to use to diagnose fevers associated with the flu since it has absolutely no contact with the skin, making for a completely hygienic and non-invasive experience; a reading is taken in a second and the thermometer is clinically proven to be accurate and safe.

About Kidz-Med, Inc.

A division of American Scientific Resources, Inc., Kidz-Med, Inc., was founded in 1993 by Dr. Christopher F. Tirotta to create children's pre-operative educational videos "A Hospital Trip With Dr. Bip" and "Dr. Bip's New Baby Tips". Today, Kidz-Med, Inc. is leading the pediatric and children's health and safety products industry in innovation by providing the most revolutionary patented family-friendly products sourced from around the globe to help keep children safe and parents reassured. For additional information, visit or

Safe Harbor

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

    Ronald Garner
    Investor Hotline:

SOURCE Kidz-Med Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide
2. The Doctors Diagnose the Kidz-Med Thermofocus
3. Parents Day is Coming - Kidz-Med Celebrates the Role of Parents
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a ... customers 10% off of their purchase of lice treatment product. In addition, customers will ... to a company spokesperson. “Finding lice is a sure way to ruin the holidays, ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    --> Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ...
(Date:11/27/2015)... , November 27, 2015 ... set to go online. The potential to save costs, ... vast and far from fully exploited as yet. Here, ... health records, either via mobile tablet or directly at ... --> ) -->      ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   Clinical Cancer ... --> Clinical Cancer Research vom 6. ...
Breaking Medicine Technology: